
Merck, Pfizer and Eli Lilly forge partnership.

NACDS president issues position statement.

The primary efficacy endpoints will be pain relief, and diminished nausea, photophobia, and phonophobia.

The "Organized Retail Crime Act of 2008" (H.R. 6491) would modify current federal criminal code to confront, prevent and penalize organized retail crime.

The lawsuit is one of three supported by pharmaceutical interests.

It's unclear whether FDA will seek further review by the U.S. Supreme Court.

National Lipid Association issued a statement regarding new cholesterol guidelines for children.

Doctors place great emphasis on their clinical judgment and experience.

More and more pharmacies are using interactive voice response systems to improve patients' drug compliance.

This change will allow the company greater flexibility to invest in its core strategies.

Letter will inform companies that the drug review period is complete and that their application is not yet ready for approval.

There is a risk that damaged vials may lead to a loss in sterility.

CVS/Pharmacy donates $300,000 to project.

Docusys is a new software that improves anesthesia safety, according to hospitals that have tried it.

Entereg is cleared to restore bowel function to patients who have undergone abdominal surgery.

Here are highlights from the most recent ASH meeting.

The NCCN compendium will be used as a source for making chemo drug benefit decisions under Part B.

Pharmacy owners should have an exit strategy mapped out for their business.

New technology news for pharmacists.

New drugs, indications, generics, and over-the-counter products for sale in pharmacies.

A growing number of retail pharmacies are looking to automation technology as they expand their businesses beyond lick, stick, and pour.

A delay in AMP implementation, prompt pay for Medicare Part D claims, and e-pedigree are among the major issues addressed at the NCPA legislative show.

Manufacturers are unleashing new oral care over-the-counter products that are innovative.

John Gans tallks candidly about his role at APhA, his departure from APhA and other timely matters affecting the future of pharmacy.

NHLBI debuts new guidelines for treatment of von Willebrand Disease

At the AHIP annual meeting, CVS Caremark announced a new approach to managing patients' medication needs.

Impressive study results lead to new Velcade indication.

Now pediatric patients, too, can take Aptpivus to treat HIV.

Tamsulosin and dutasteride combination approved by FDA.

In settling a class action suit, the Centers for Medicare & Medicaid Services has agreed to make changes to the low income subsidy program for Medicare Part D.